Diabetes medication(s)-Insulin - Page 3 of 5 Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Insulin Posts on Medivizor

Large changes in day-to-day blood sugar levels and the risk of hypoglycemia

Posted by on Nov 10, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the association between the day-to-day self-monitored blood glucose level differences and the risk of hypoglycemia in insulin-treated patients with type 1 and type 2 diabetes. The study found that bigger differences in day-to-day blood glucose levels were associated with a higher risk of hypoglycemia...

Read More

Looking for people with type 1 diabetes to try an artificial pancreas

Posted by on Sep 1, 2018 in Diabetes mellitus | 0 comments

In a nutshell This clinical trial is investigating the effects of an artificial pancreas (AP) system on brain function in older adults with type 1 diabetes (T1D). The main outcome to be measured will be change in alternate fuel uptake by the brain during hypoglycemia (dangerously low blood glucose). The details Glucose is used as fuel by the brain and...

Read More

Remember the protein: calculating meal-time insulin dosing in type 1 diabetes

Posted by on Jun 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether the meal-time insulin dose should be calculated based on the carbohydrate count or the combination of carbohydrate plus protein. The study concluded that calculating the dose based on both carbohydrate and protein may be more effective. Some background Patients with type 1 diabetes can benefit from a...

Read More

Effectiveness and safety of faster aspart

Posted by on Feb 17, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of fast-acting insulin aspart (faster aspart) with conventional insulin aspart (IAsp) in people with type 1 diabetes (T1D). It was determined that faster aspart may be better at controlling blood glucose levels, without increasing the risk of side effects. Some background Reducing...

Read More

Safety and effectiveness of insulin glargine

Posted by on Jan 26, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and safety of two forms of insulin glargine in people with type 2 diabetes (T2D). It determined that both forms reduced HbA1c (measures average blood glucose over the last 3 months), but the more concentrated form was less likely to cause hypoglycemia (dangerously low blood glucose). Some background...

Read More

Searching for adults and children with type 1 diabetes to test the hybrid closed loop insulin delivery system

Posted by on Dec 19, 2017 in Diabetes mellitus | 0 comments

In a nutshell This trial will evaluate the safety and effectiveness of the Hybrid Closed Loop (HCL) system in adult and pediatric patients with type 1 diabetes. The primary outcome of this study will be a change in HbA1c levels (average blood glucose over 3 months). The details HCL systems are a diabetes management strategy. They are composed of...

Read More

Glyburide: a safe and effective medication for the treatment of gestational diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if glyburide (Glynase) was safer and more effective than insulin in patients with gestational diabetes. They found that glyburide was associated with an increased risk of neonatal hypoglycemia (low blood sugar) but was well tolerated overall.  Some background Gestational diabetes mellitus (GDM)...

Read More

Can a bionic pancreas effectively provide day-to-day glycemic control in patients with type 1 diabetes?

Posted by on Aug 8, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if a bionic pancreas, that releases insulin and glucagon (bihormonal), could improve glycemic (blood sugar) control in patients with type 1 diabetes. They found that the bionic pancreas was more effective than a conventional insulin pump in monitoring and managing glycemia in these patients. Some background...

Read More

Does IDegLira improve outcomes in patients with uncontrolled type 2 diabetes?

Posted by on Aug 8, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the effects of IDegLira, a combination insulin drug, on outcomes in patients with uncontrolled type 2 diabetes. They found that IDegLira improved glycemic (blood sugar) control and aided weight loss in these patients. Some background The treatment of type 2 diabetes is to achieve glycemic control. This can slow...

Read More